Zion, O., Institute of Animal Science, ARO, Volcani Center, Bet Dagan 50250, Israel Genin, O., Institute of Animal Science, ARO, Volcani Center, Bet Dagan 50250, Israel Kawada, N., Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan Yoshizato, K., Department of Biological Science, Graduate School of Science, Hiroshima University, Japan Roffe, S., Department of Animal Sciences, Hebrew University of Jerusalem, Rehovot, Israel Nagler, A., Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel Iovanna, J.L., INSERM U624, Stress Cellulaire, Campus de Luminy, Marseille, France Halevy, O., Department of Animal Sciences, Hebrew University of Jerusalem, Rehovot, Israel Pines, M., Institute of Animal Science, ARO, Volcani Center, Bet Dagan 50250, Israel
Inhibition of transforming growth factor β signaling by halofuginone as a modality for pancreas fibrosis prevention
38
Zion, O., Institute of Animal Science, ARO, Volcani Center, Bet Dagan 50250, Israel Genin, O., Institute of Animal Science, ARO, Volcani Center, Bet Dagan 50250, Israel Kawada, N., Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan Yoshizato, K., Department of Biological Science, Graduate School of Science, Hiroshima University, Japan Roffe, S., Department of Animal Sciences, Hebrew University of Jerusalem, Rehovot, Israel Nagler, A., Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel Iovanna, J.L., INSERM U624, Stress Cellulaire, Campus de Luminy, Marseille, France Halevy, O., Department of Animal Sciences, Hebrew University of Jerusalem, Rehovot, Israel Pines, M., Institute of Animal Science, ARO, Volcani Center, Bet Dagan 50250, Israel
Inhibition of transforming growth factor β signaling by halofuginone as a modality for pancreas fibrosis prevention